Join
Live feed
·
INSIDERFilingvia Quantisnow
Monopar Therapeutics Inc. logo

Chief Operating Officer Cittadine Andrew converted options into 8,952 shares and covered exercise/tax liability with 2,019 shares, increasing direct ownership by 4% to 193,065 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MNPR (Monopar Therapeutics Inc.) and more on Quantisnow.